{"id":"https://openalex.org/W2017257127","doi":"https://doi.org/10.1124/jpet.112.196519","title":"Synthetic Farnesoid X Receptor Agonists Induce High-Density Lipoprotein-Mediated Transhepatic Cholesterol Efflux in Mice and Monkeys and Prevent Atherosclerosis in Cholesteryl Ester Transfer Protein Transgenic Low-Density Lipoprotein Receptor (\u2212/\u2212) Mice","display_name":"Synthetic Farnesoid X Receptor Agonists Induce High-Density Lipoprotein-Mediated Transhepatic Cholesterol Efflux in Mice and Monkeys and Prevent Atherosclerosis in Cholesteryl Ester Transfer Protein Transgenic Low-Density Lipoprotein Receptor (\u2212/\u2212) Mice","publication_year":2012,"publication_date":"2012-08-24","ids":{"openalex":"https://openalex.org/W2017257127","doi":"https://doi.org/10.1124/jpet.112.196519","mag":"2017257127","pmid":"https://pubmed.ncbi.nlm.nih.gov/22918042","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11047796"},"language":"en","primary_location":{"id":"doi:10.1124/jpet.112.196519","doi":"https://doi.org/10.1124/jpet.112.196519","is_oa":false,"landing_page_url":"https://doi.org/10.1124/jpet.112.196519","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11047796","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088100389","display_name":"Eva Hambruch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3129555431","display_name":"University Hospital Regensburg","ror":"https://ror.org/01226dv09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3129555431"]},{"id":"https://openalex.org/I4210093041","display_name":"Phenex Pharmaceuticals (Germany)","ror":"https://ror.org/00g3t5227","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210093041"]},{"id":"https://openalex.org/I4210122049","display_name":"Synovo (Germany)","ror":"https://ror.org/02rrff887","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122049"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Eva Hambruch","raw_affiliation_strings":["Phenex Pharmaceuticals AG, Heidelberg, Germany","Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany","institution_ids":["https://openalex.org/I4210093041"]},{"raw_affiliation_string":"Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431"]},{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","institution_ids":["https://openalex.org/I4210093041"]},{"raw_affiliation_string":"Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)","institution_ids":["https://openalex.org/I4210122049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023340444","display_name":"Shinobu Miyazaki\u2010Anzai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3129555431","display_name":"University Hospital Regensburg","ror":"https://ror.org/01226dv09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3129555431"]},{"id":"https://openalex.org/I4210093041","display_name":"Phenex Pharmaceuticals (Germany)","ror":"https://ror.org/00g3t5227","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210093041"]},{"id":"https://openalex.org/I4210122049","display_name":"Synovo (Germany)","ror":"https://ror.org/02rrff887","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122049"]},{"id":"https://openalex.org/I60668342","display_name":"University of Regensburg","ror":"https://ror.org/01eezs655","country_code":"DE","type":"education","lineage":["https://openalex.org/I60668342"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Shinobu Miyazaki-Anzai","raw_affiliation_strings":["Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431","https://openalex.org/I4210093041","https://openalex.org/I60668342","https://openalex.org/I921990950"]},{"raw_affiliation_string":"Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431"]},{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","institution_ids":["https://openalex.org/I4210093041"]},{"raw_affiliation_string":"Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)","institution_ids":["https://openalex.org/I4210122049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106034783","display_name":"Ulrike K. Hahn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3129555431","display_name":"University Hospital Regensburg","ror":"https://ror.org/01226dv09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3129555431"]},{"id":"https://openalex.org/I4210093041","display_name":"Phenex Pharmaceuticals (Germany)","ror":"https://ror.org/00g3t5227","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210093041"]},{"id":"https://openalex.org/I4210122049","display_name":"Synovo (Germany)","ror":"https://ror.org/02rrff887","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122049"]},{"id":"https://openalex.org/I60668342","display_name":"University of Regensburg","ror":"https://ror.org/01eezs655","country_code":"DE","type":"education","lineage":["https://openalex.org/I60668342"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Ulrike Hahn","raw_affiliation_strings":["Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431","https://openalex.org/I4210093041","https://openalex.org/I60668342","https://openalex.org/I921990950"]},{"raw_affiliation_string":"Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431"]},{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","institution_ids":["https://openalex.org/I4210093041"]},{"raw_affiliation_string":"Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)","institution_ids":["https://openalex.org/I4210122049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062189438","display_name":"Silke Matysik","orcid":"https://orcid.org/0000-0001-8590-8154","observed_orcids":["https://orcid.org/0000-0001-8590-8154"]},"institutions":[{"id":"https://openalex.org/I3129555431","display_name":"University Hospital Regensburg","ror":"https://ror.org/01226dv09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3129555431"]},{"id":"https://openalex.org/I4210093041","display_name":"Phenex Pharmaceuticals (Germany)","ror":"https://ror.org/00g3t5227","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210093041"]},{"id":"https://openalex.org/I4210122049","display_name":"Synovo (Germany)","ror":"https://ror.org/02rrff887","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122049"]},{"id":"https://openalex.org/I60668342","display_name":"University of Regensburg","ror":"https://ror.org/01eezs655","country_code":"DE","type":"education","lineage":["https://openalex.org/I60668342"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Silke Matysik","raw_affiliation_strings":["Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431","https://openalex.org/I4210093041","https://openalex.org/I60668342","https://openalex.org/I921990950"]},{"raw_affiliation_string":"Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431"]},{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","institution_ids":["https://openalex.org/I4210093041"]},{"raw_affiliation_string":"Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)","institution_ids":["https://openalex.org/I4210122049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024189740","display_name":"Alfred Boettcher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3129555431","display_name":"University Hospital Regensburg","ror":"https://ror.org/01226dv09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3129555431"]},{"id":"https://openalex.org/I4210093041","display_name":"Phenex Pharmaceuticals (Germany)","ror":"https://ror.org/00g3t5227","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210093041"]},{"id":"https://openalex.org/I4210122049","display_name":"Synovo (Germany)","ror":"https://ror.org/02rrff887","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122049"]},{"id":"https://openalex.org/I60668342","display_name":"University of Regensburg","ror":"https://ror.org/01eezs655","country_code":"DE","type":"education","lineage":["https://openalex.org/I60668342"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Alfred Boettcher","raw_affiliation_strings":["Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431","https://openalex.org/I4210093041","https://openalex.org/I60668342","https://openalex.org/I921990950"]},{"raw_affiliation_string":"Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431"]},{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","institution_ids":["https://openalex.org/I4210093041"]},{"raw_affiliation_string":"Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)","institution_ids":["https://openalex.org/I4210122049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051993305","display_name":"Sanja Perovi\u0107\u2010Ottstadt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3129555431","display_name":"University Hospital Regensburg","ror":"https://ror.org/01226dv09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3129555431"]},{"id":"https://openalex.org/I4210093041","display_name":"Phenex Pharmaceuticals (Germany)","ror":"https://ror.org/00g3t5227","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210093041"]},{"id":"https://openalex.org/I4210122049","display_name":"Synovo (Germany)","ror":"https://ror.org/02rrff887","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122049"]},{"id":"https://openalex.org/I60668342","display_name":"University of Regensburg","ror":"https://ror.org/01eezs655","country_code":"DE","type":"education","lineage":["https://openalex.org/I60668342"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Sanja Perovi\u0107-Ottstadt","raw_affiliation_strings":["Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431","https://openalex.org/I4210093041","https://openalex.org/I60668342","https://openalex.org/I921990950"]},{"raw_affiliation_string":"Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431"]},{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","institution_ids":["https://openalex.org/I4210093041"]},{"raw_affiliation_string":"Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)","institution_ids":["https://openalex.org/I4210122049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113444190","display_name":"Thomas Schl\u00fcter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3129555431","display_name":"University Hospital Regensburg","ror":"https://ror.org/01226dv09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3129555431"]},{"id":"https://openalex.org/I4210093041","display_name":"Phenex Pharmaceuticals (Germany)","ror":"https://ror.org/00g3t5227","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210093041"]},{"id":"https://openalex.org/I4210122049","display_name":"Synovo (Germany)","ror":"https://ror.org/02rrff887","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122049"]},{"id":"https://openalex.org/I60668342","display_name":"University of Regensburg","ror":"https://ror.org/01eezs655","country_code":"DE","type":"education","lineage":["https://openalex.org/I60668342"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Thomas Schl\u00fcter","raw_affiliation_strings":["Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431","https://openalex.org/I4210093041","https://openalex.org/I60668342","https://openalex.org/I921990950"]},{"raw_affiliation_string":"Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431"]},{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","institution_ids":["https://openalex.org/I4210093041"]},{"raw_affiliation_string":"Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)","institution_ids":["https://openalex.org/I4210122049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018725184","display_name":"Olaf D. Kinzel","orcid":"https://orcid.org/0000-0001-7357-2833","observed_orcids":["https://orcid.org/0000-0001-7357-2833"]},"institutions":[{"id":"https://openalex.org/I3129555431","display_name":"University Hospital Regensburg","ror":"https://ror.org/01226dv09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3129555431"]},{"id":"https://openalex.org/I4210093041","display_name":"Phenex Pharmaceuticals (Germany)","ror":"https://ror.org/00g3t5227","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210093041"]},{"id":"https://openalex.org/I4210122049","display_name":"Synovo (Germany)","ror":"https://ror.org/02rrff887","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122049"]},{"id":"https://openalex.org/I60668342","display_name":"University of Regensburg","ror":"https://ror.org/01eezs655","country_code":"DE","type":"education","lineage":["https://openalex.org/I60668342"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Olaf Kinzel","raw_affiliation_strings":["Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431","https://openalex.org/I4210093041","https://openalex.org/I60668342","https://openalex.org/I921990950"]},{"raw_affiliation_string":"Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431"]},{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","institution_ids":["https://openalex.org/I4210093041"]},{"raw_affiliation_string":"Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)","institution_ids":["https://openalex.org/I4210122049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050623920","display_name":"Helen Desiree Krol","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3129555431","display_name":"University Hospital Regensburg","ror":"https://ror.org/01226dv09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3129555431"]},{"id":"https://openalex.org/I4210093041","display_name":"Phenex Pharmaceuticals (Germany)","ror":"https://ror.org/00g3t5227","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210093041"]},{"id":"https://openalex.org/I4210122049","display_name":"Synovo (Germany)","ror":"https://ror.org/02rrff887","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122049"]},{"id":"https://openalex.org/I60668342","display_name":"University of Regensburg","ror":"https://ror.org/01eezs655","country_code":"DE","type":"education","lineage":["https://openalex.org/I60668342"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Helen Desiree Krol","raw_affiliation_strings":["Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431","https://openalex.org/I4210093041","https://openalex.org/I60668342","https://openalex.org/I921990950"]},{"raw_affiliation_string":"Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431"]},{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","institution_ids":["https://openalex.org/I4210093041"]},{"raw_affiliation_string":"Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)","institution_ids":["https://openalex.org/I4210122049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046365471","display_name":"Ulrich Deuschle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3129555431","display_name":"University Hospital Regensburg","ror":"https://ror.org/01226dv09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3129555431"]},{"id":"https://openalex.org/I4210093041","display_name":"Phenex Pharmaceuticals (Germany)","ror":"https://ror.org/00g3t5227","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210093041"]},{"id":"https://openalex.org/I4210122049","display_name":"Synovo (Germany)","ror":"https://ror.org/02rrff887","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122049"]},{"id":"https://openalex.org/I60668342","display_name":"University of Regensburg","ror":"https://ror.org/01eezs655","country_code":"DE","type":"education","lineage":["https://openalex.org/I60668342"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Ulrich Deuschle","raw_affiliation_strings":["Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431","https://openalex.org/I4210093041","https://openalex.org/I60668342","https://openalex.org/I921990950"]},{"raw_affiliation_string":"Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431"]},{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","institution_ids":["https://openalex.org/I4210093041"]},{"raw_affiliation_string":"Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)","institution_ids":["https://openalex.org/I4210122049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037175873","display_name":"Michael W. M. Burnet","orcid":"https://orcid.org/0000-0003-4311-5441","observed_orcids":["https://orcid.org/0000-0003-4311-5441"]},"institutions":[{"id":"https://openalex.org/I3129555431","display_name":"University Hospital Regensburg","ror":"https://ror.org/01226dv09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3129555431"]},{"id":"https://openalex.org/I4210093041","display_name":"Phenex Pharmaceuticals (Germany)","ror":"https://ror.org/00g3t5227","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210093041"]},{"id":"https://openalex.org/I4210122049","display_name":"Synovo (Germany)","ror":"https://ror.org/02rrff887","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122049"]},{"id":"https://openalex.org/I60668342","display_name":"University of Regensburg","ror":"https://ror.org/01eezs655","country_code":"DE","type":"education","lineage":["https://openalex.org/I60668342"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Michael Burnet","raw_affiliation_strings":["Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431","https://openalex.org/I4210093041","https://openalex.org/I60668342","https://openalex.org/I921990950"]},{"raw_affiliation_string":"Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431"]},{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","institution_ids":["https://openalex.org/I4210093041"]},{"raw_affiliation_string":"Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)","institution_ids":["https://openalex.org/I4210122049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003449456","display_name":"Moshe Levi","orcid":"https://orcid.org/0000-0002-6225-946X","observed_orcids":["https://orcid.org/0000-0002-6225-946X"]},"institutions":[{"id":"https://openalex.org/I3129555431","display_name":"University Hospital Regensburg","ror":"https://ror.org/01226dv09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3129555431"]},{"id":"https://openalex.org/I4210093041","display_name":"Phenex Pharmaceuticals (Germany)","ror":"https://ror.org/00g3t5227","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210093041"]},{"id":"https://openalex.org/I4210122049","display_name":"Synovo (Germany)","ror":"https://ror.org/02rrff887","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122049"]},{"id":"https://openalex.org/I60668342","display_name":"University of Regensburg","ror":"https://ror.org/01eezs655","country_code":"DE","type":"education","lineage":["https://openalex.org/I60668342"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Moshe Levi","raw_affiliation_strings":["Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431","https://openalex.org/I4210093041","https://openalex.org/I60668342","https://openalex.org/I921990950"]},{"raw_affiliation_string":"Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431"]},{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","institution_ids":["https://openalex.org/I4210093041"]},{"raw_affiliation_string":"Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)","institution_ids":["https://openalex.org/I4210122049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070833222","display_name":"Gerd Schmitz","orcid":"https://orcid.org/0000-0002-1325-1007","observed_orcids":["https://orcid.org/0000-0002-1325-1007"]},"institutions":[{"id":"https://openalex.org/I3129555431","display_name":"University Hospital Regensburg","ror":"https://ror.org/01226dv09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3129555431"]},{"id":"https://openalex.org/I4210093041","display_name":"Phenex Pharmaceuticals (Germany)","ror":"https://ror.org/00g3t5227","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210093041"]},{"id":"https://openalex.org/I4210122049","display_name":"Synovo (Germany)","ror":"https://ror.org/02rrff887","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122049"]},{"id":"https://openalex.org/I60668342","display_name":"University of Regensburg","ror":"https://ror.org/01eezs655","country_code":"DE","type":"education","lineage":["https://openalex.org/I60668342"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Gerd Schmitz","raw_affiliation_strings":["Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431","https://openalex.org/I4210093041","https://openalex.org/I60668342","https://openalex.org/I921990950"]},{"raw_affiliation_string":"Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431"]},{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","institution_ids":["https://openalex.org/I4210093041"]},{"raw_affiliation_string":"Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)","institution_ids":["https://openalex.org/I4210122049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032236530","display_name":"Makoto Miyazaki","orcid":"https://orcid.org/0000-0002-8704-8511","observed_orcids":["https://orcid.org/0000-0002-8704-8511"]},"institutions":[{"id":"https://openalex.org/I3129555431","display_name":"University Hospital Regensburg","ror":"https://ror.org/01226dv09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3129555431"]},{"id":"https://openalex.org/I4210093041","display_name":"Phenex Pharmaceuticals (Germany)","ror":"https://ror.org/00g3t5227","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210093041"]},{"id":"https://openalex.org/I4210122049","display_name":"Synovo (Germany)","ror":"https://ror.org/02rrff887","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122049"]},{"id":"https://openalex.org/I60668342","display_name":"University of Regensburg","ror":"https://ror.org/01eezs655","country_code":"DE","type":"education","lineage":["https://openalex.org/I60668342"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Makoto Miyazaki","raw_affiliation_strings":["Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431","https://openalex.org/I4210093041","https://openalex.org/I60668342","https://openalex.org/I921990950"]},{"raw_affiliation_string":"Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431"]},{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","institution_ids":["https://openalex.org/I4210093041"]},{"raw_affiliation_string":"Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)","institution_ids":["https://openalex.org/I4210122049"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062783070","display_name":"Claus Kremoser","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3129555431","display_name":"University Hospital Regensburg","ror":"https://ror.org/01226dv09","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3129555431"]},{"id":"https://openalex.org/I4210093041","display_name":"Phenex Pharmaceuticals (Germany)","ror":"https://ror.org/00g3t5227","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210093041"]},{"id":"https://openalex.org/I4210122049","display_name":"Synovo (Germany)","ror":"https://ror.org/02rrff887","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210122049"]},{"id":"https://openalex.org/I60668342","display_name":"University of Regensburg","ror":"https://ror.org/01eezs655","country_code":"DE","type":"education","lineage":["https://openalex.org/I60668342"]},{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Claus Kremoser","raw_affiliation_strings":["Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.); Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.); Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.); and Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431","https://openalex.org/I4210093041","https://openalex.org/I60668342","https://openalex.org/I921990950"]},{"raw_affiliation_string":"Division of Renal Diseases and Hypertension, University of Colorado, Denver, Colorado (S.M.-A., M.L., M.M.)","institution_ids":["https://openalex.org/I921990950"]},{"raw_affiliation_string":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany (S.M., A.B., G.S.)","institution_ids":["https://openalex.org/I3129555431"]},{"raw_affiliation_string":"Phenex Pharmaceuticals AG, Heidelberg, Germany (E.H., S.P.-O., T.S., O.K., H.D.K., U.D., C.K.)","institution_ids":["https://openalex.org/I4210093041"]},{"raw_affiliation_string":"Synovo GmbH, T\u00fcbingen, Germany (U.H., M.B.)","institution_ids":["https://openalex.org/I4210122049"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":3.806,"has_fulltext":false,"cited_by_count":100,"citation_normalized_percentile":{"value":0.94904037,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"343","issue":"3","first_page":"556","last_page":"567"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/farnesoid-x-receptor-agonist","display_name":"farnesoid X receptor agonist","score":0.9440000057220459},{"id":"https://openalex.org/keywords/high-density-lipoprotein","display_name":"high-density lipoprotein","score":0.9150000214576721},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.7919999957084656},{"id":"https://openalex.org/keywords/cetp-transgenic-mice","display_name":"CETP transgenic mice","score":0.652999997138977},{"id":"https://openalex.org/keywords/ldlr-knockout-mice","display_name":"Ldlr knockout mice","score":0.8399999737739563},{"id":"https://openalex.org/keywords/cholesterol-homeostasis","display_name":"cholesterol homeostasis","score":0.7459999918937683},{"id":"https://openalex.org/keywords/plasma-lipoproteins","display_name":"serum lipoproteins","score":0.8289999961853027},{"id":"https://openalex.org/keywords/fecal-cholesterol-excretion","display_name":"fecal cholesterol excretion","score":0.9089999794960022},{"id":"https://openalex.org/keywords/intestinal-cholesterol-absorption","display_name":"intestinal cholesterol absorption","score":0.8429999947547913},{"id":"https://openalex.org/keywords/gw4064","display_name":"GW4064","score":0.7889999747276306},{"id":"https://openalex.org/keywords/chenodeoxycholic-acid","display_name":"chenodeoxycholic acid","score":0.871999979019165}],"concepts":[{"id":"https://openalex.org/C203862802","wikidata":"https://www.wikidata.org/wiki/Q14905041","display_name":"Farnesoid X receptor","level":5,"score":0.8169940114021301},{"id":"https://openalex.org/C45505151","wikidata":"https://www.wikidata.org/wiki/Q424706","display_name":"Cholesterylester transfer protein","level":4,"score":0.7790120244026184},{"id":"https://openalex.org/C141035611","wikidata":"https://www.wikidata.org/wiki/Q5532934","display_name":"Genetically modified mouse","level":4,"score":0.6238021850585938},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.6042789816856384},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.5905845761299133},{"id":"https://openalex.org/C174782155","wikidata":"https://www.wikidata.org/wiki/Q18032613","display_name":"Low-density lipoprotein receptor-related protein 8","level":5,"score":0.5790136456489563},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5776277780532837},{"id":"https://openalex.org/C43554185","wikidata":"https://www.wikidata.org/wiki/Q425649","display_name":"LDL receptor","level":4,"score":0.564492404460907},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.559353768825531},{"id":"https://openalex.org/C102230213","wikidata":"https://www.wikidata.org/wiki/Q430117","display_name":"Transgene","level":3,"score":0.5390275120735168},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5366930365562439},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43589353561401367},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33703944087028503},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29941558837890625},{"id":"https://openalex.org/C8243546","wikidata":"https://www.wikidata.org/wiki/Q419074","display_name":"Very low-density lipoprotein","level":4,"score":0.2746146321296692},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.25446826219558716},{"id":"https://openalex.org/C63932345","wikidata":"https://www.wikidata.org/wiki/Q422500","display_name":"Nuclear receptor","level":4,"score":0.1264379918575287},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09641018509864807},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000099150","descriptor_name":"Receptor, Farnesoid X-Activated","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001011","descriptor_name":"Aorta","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001011","descriptor_name":"Aorta","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001011","descriptor_name":"Aorta","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001565","descriptor_name":"Benzoates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001565","descriptor_name":"Benzoates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001565","descriptor_name":"Benzoates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001692","descriptor_name":"Biological Transport","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005243","descriptor_name":"Feces","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008075","descriptor_name":"Lipoproteins, HDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011973","descriptor_name":"Receptors, LDL","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011973","descriptor_name":"Receptors, LDL","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013045","descriptor_name":"Species Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018160","descriptor_name":"Receptors, Cytoplasmic and Nuclear","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053480","descriptor_name":"Cholesterol Ester Transfer Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D053480","descriptor_name":"Cholesterol Ester Transfer Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D059305","descriptor_name":"Diet, High-Fat","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1124/jpet.112.196519","doi":"https://doi.org/10.1124/jpet.112.196519","is_oa":false,"landing_page_url":"https://doi.org/10.1124/jpet.112.196519","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11047796","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11047796","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Pharmacol Exp Ther","raw_type":"Text"},{"id":"pmid:22918042","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22918042","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacology and experimental therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:epub.uni-regensburg.de:63101","doi":null,"is_oa":false,"landing_page_url":"http://orcid.org/0000-0002-6225-946X>,","pdf_url":null,"source":{"id":"https://openalex.org/S4306401229","display_name":"University of Regensburg Publication Server (University of Regensburg)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I60668342","host_organization_name":"University of Regensburg","host_organization_lineage":["https://openalex.org/I60668342"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.1012.1944","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1012.1944","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jpet.aspetjournals.org/content/early/2012/08/23/jpet.112.196519.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:11047796","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11047796","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Pharmacol Exp Ther","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8028685875","display_name":"Treatment of Kidney Disease in Diabetes and Obesity","funder_award_id":"R01DK098336","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G8034811188","display_name":null,"funder_award_id":"I01 BX001954","funder_id":"https://openalex.org/F4320306127","funder_display_name":"U.S. Department of Veterans Affairs"},{"id":"https://openalex.org/G9000884917","display_name":"Colorado Nutrition Obesity Research Center","funder_award_id":"P30DK048520","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"}],"funders":[{"id":"https://openalex.org/F4320306127","display_name":"U.S. Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":71,"referenced_works":["https://openalex.org/W1626021976","https://openalex.org/W1763892101","https://openalex.org/W1966052494","https://openalex.org/W1975673963","https://openalex.org/W1983811928","https://openalex.org/W1983871162","https://openalex.org/W1984362422","https://openalex.org/W1987525850","https://openalex.org/W1990819179","https://openalex.org/W1995076942","https://openalex.org/W1997864253","https://openalex.org/W1999547106","https://openalex.org/W2001987612","https://openalex.org/W2003008866","https://openalex.org/W2003716266","https://openalex.org/W2005911243","https://openalex.org/W2008536703","https://openalex.org/W2015618130","https://openalex.org/W2016597009","https://openalex.org/W2016716035","https://openalex.org/W2023512757","https://openalex.org/W2024639496","https://openalex.org/W2024685706","https://openalex.org/W2026540040","https://openalex.org/W2030341720","https://openalex.org/W2032482278","https://openalex.org/W2041451676","https://openalex.org/W2045223517","https://openalex.org/W2045367953","https://openalex.org/W2048070048","https://openalex.org/W2048561509","https://openalex.org/W2049515100","https://openalex.org/W2051040521","https://openalex.org/W2053581007","https://openalex.org/W2055823448","https://openalex.org/W2066561101","https://openalex.org/W2067739356","https://openalex.org/W2068458442","https://openalex.org/W2069530251","https://openalex.org/W2071114782","https://openalex.org/W2073308465","https://openalex.org/W2083034596","https://openalex.org/W2094723419","https://openalex.org/W2095919437","https://openalex.org/W2103528237","https://openalex.org/W2106678312","https://openalex.org/W2108987650","https://openalex.org/W2109221130","https://openalex.org/W2111157610","https://openalex.org/W2117349394","https://openalex.org/W2119560584","https://openalex.org/W2125031369","https://openalex.org/W2125109896","https://openalex.org/W2126082120","https://openalex.org/W2130289287","https://openalex.org/W2131287047","https://openalex.org/W2133108565","https://openalex.org/W2134358461","https://openalex.org/W2142427646","https://openalex.org/W2142789398","https://openalex.org/W2151731574","https://openalex.org/W2158609797","https://openalex.org/W2161412395","https://openalex.org/W2162017875","https://openalex.org/W2162719733","https://openalex.org/W2169283243","https://openalex.org/W2169943839","https://openalex.org/W2171398834","https://openalex.org/W2185919342","https://openalex.org/W2314766391","https://openalex.org/W4249387963"],"related_works":["https://openalex.org/W2333329900","https://openalex.org/W7099686307","https://openalex.org/W2109221130","https://openalex.org/W105421061","https://openalex.org/W2100230785","https://openalex.org/W2125031369","https://openalex.org/W2008536703","https://openalex.org/W2137388468","https://openalex.org/W2119560584","https://openalex.org/W2047664305"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}